EX-23.1 3 tgtx_ex231.htm EXHIBIT 23.1
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in registration statement Nos. 333-181439 and 333-210227 on Form S-8 and registration statement No. 333- 218293 on Form S-3 of TG Therapeutics, Inc. of our report dated March 15, 2018 on our audits of the consolidated financial statements of TG Therapeutics, Inc. and Subsidiaries as of December 31, 2017 and 2016, and for each of the three years in the period ended December 31, 2017, and our report on our audit of internal control over financial reporting of TG Therapeutics, Inc. and Subsidiaries as of December 31, 2017, dated March 15, 2018, included in this Annual Report on Form 10-K of TG Therapeutics, Inc. and Subsidiaries for the year ended December 31, 2017.
/s/ CohnReznick LLP
New York, New York
March 15, 2018